I am excited to share that my PhD work has been published in Science! This work unveils some of the molecular underpinnings of breast cancer leptomeningeal metastasis, a devastating clinical complication with limited treatment options. science.org/doi/10.1126/sc…

Night shifts can be brutal 😫 Here are five tips to surviving the night shift based on my experience as a paramedic, medical student, resident, and now attending ICU physician. 🚑 Number 4 could save your life ☠️ #meded #residents #foamed

🎗️July is sarcoma awareness month. We need to raise awareness of this rare disease to facilitate accurate diagnosis and treatment ❗️#SarcomaAwarenessMonth

🌟 The first ESMO Preceptorship on Uterine Cancer has been a great success! Proud to have co-chaired this important educational event with the super Prof. Ray-Coquard. 🙏🏻 I can’t thank enough the outstanding faculty, all the attendees and the fantastic ESMO staff ESMO - Eur. Oncology

📘Systemic Therapy in Breast Cancer ASCO Educational Book ✅An excellent review with summary tables of practice changing trials 👉doi.org/10.1200/EDBK_4… Journal of Clinical Oncology JCO Precision Oncology JCO Oncology Practice The ASCO Post OncoAlert #cancer #oncology #breast #MedX

Fantastic and comprehensive review on emerging mechanisms of T cell dysfunction in cancer and strategies to overcome them by Caitlin Zebley, MD PhD The Zehn Lab Stephen Gottschalk Hongbo Chi nature.com/articles/s4159…

📰 European Journal of Cancer just #published my #review on what patients can influence themselves when starting #immunotherapy. I summarize the evidence behind 🍽 , 💊 and 👟, highlighting patient #empowerment. ➡️doi.org/10.1016/j.ejca…

When a patient copes with serious illness by joking and laughing, his palliative care physician must assess whether she should lean into his humor or lead him away from it. Read the Perspective by Dr. Danielle Chammas: nej.md/4cK3X5f

Came across this beautiful statement in the streets of Münich during the #ESMO Preceptorship on Breast Cancer last week. Had to reflect on case of an aggressive #TNBC in a young woman (cases we can all rely with). Thank you ESMO - Eur. Oncology for these important courses. 🎗️

Ready for the semis 👀🔥 21h00 live on RTBF Sport and sporza #basketballbelgium #teambelgium #Paris2024

Dose-dense vs. 3-weekly AC during neoadjuvant chemoimmunotherapy for TNBC Interesting real-world data addressing an important question for clinical practice No statistical significant difference observed; numerical ⬆️pCR for ddAC in stage 3️⃣ OncoAlert nature.com/articles/s4152…

#ScienceSaturday The combination of anti-CTLA-4 and anti-PD-1 antibodies is FDA approved for the treatment of advanced #melanoma. How does this combination work mechanistically? In a recently published study in Cancer Cell using both single cell TCR and RNA sequencing, Wang

Best poster award for @uzbrussel PhD student Manon Vounckx with her melanoma poster on intralesional dendritic cells with AS01 and ipilimumab a phase 1 trial👏

🙌 Congratulations to the best abstracts Awardees of #ESHIMMUNE2024: Sylvain Simon, Martina Spiga, Gabriele Inchingolo, Elise Sylvander, Sabrina Wagner Conference chairs: Chiara Bonini, Michael Hudecek & Stanley Riddell #ESHCONFERENCES #HAEMATOLOGY #HEMATOLOGY

Best poster award for PhD student Nathalie Van Laer from UZ Brussel for her research on psychological issues and nzurocognitive functioning in long-term advanced cancer survivors treated with ICI #ESMO2024

Epigenetic regulation of PD-1 in mice via exhausted CD8 T cell restricted deletion of enhancer creating a ‘sweet spot’ of intermediate PD-1 expression enabling optimal T cell function for control of chronic infection Debattama Sen Nature Immunology nature.com/articles/s4159…

Happy to invite you all to the beautiful city of Ghent for the 2025 Annual meeting of SIOG. #SIOG2024

📢New editorial in press: Breaking the link: IL-6 targeting to uncouple toxicity and efficacy in patients treated with immune checkpoint blockade Matthieu Roulleaux Dugage doi.org/10.1016/j.anno…

L'Institut INFINITy a le plaisir d'accueillir 👉Magali Irla 👉Eliané Piaggio 👉Stanislas Goriely, le vendredi 20 décembre de 9h30 à 12h00. Retrouvez toutes les informations utiles sur l'affiche jointe. Espérant vous voir nombreux !🙂

Thrilled to share our Science Immunology paper! Rodent PD-1 is weaker than human PD-1 (reduced ligand binding & signaling) & lacks a conserved vertebrate motif. Humanizing mouse PD-1 disrupts T cell anti-tumor responses, raising many questions. Kudos to Takeya Masubuchi for leading